He talks about which metabolic pathways are targeted when treating nonalcoholic fatty liver disease. He recently spoke about this topic at the 21st Annual Harvard Nutrition and Obesity Symposium on NAFLD. ...
In this video, Laura T. Safar, MD, gives an overview of psychotropic treatment classes, their uses in the management of neuropsychiatric disorders among patients with multiple sclerosis, and important...
Ralph A. DeFronzo, MD, discusses the utilization of glucagon-like peptide-1 agonists and incorporating evidence-based guidelines into practice when considering the use of incretin-based therapies for type 2...
In this video, Steven Grinspoon, MD, talks about the association between HIV and Steatosis and why patients with HIV are at an increased risk of steatosis.
